跳至主要内容
临床试验/NCT02633670
NCT02633670已完成不适用

A Prospective Randomized Trial of Hemopatch Versus No Hemopatch For the Intraoperative Hemostasis During Deceased Donor Renal Transplant

St. Joseph's Healthcare Hamilton2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2016年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Blood Loss

研究概览

简要总结

Kidney transplantation remains one of the most common organ transplanted today but the surgical technique has changed very little from the original pelvic operation. The deceased donor renal transplant poses a particular challenge to the surgeon due to lack of detailed pre operative vascular assessment. The hemopatch is a promising new sealing synthetic hemostatIc agent with a novel dual mechanism of action that is more convenient to apply rather then using other hemostatic agents, which require warming and/or mixing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients at least 18 years of age and capable of giving informed consent
  • Patients scheduled for deceased donor renal transplant surgery

排除标准

  • Patient undergoing live related transplant surgery.
  • Patient having uncorrectable bleeding diathesis.
  • Any patient in the no hemopatch group requiring additional haemostatic agents for achieving hemostasis like fibrillar or surgical.

结局指标

主要结局

Blood Loss

时间窗: Baseline (Intraoperatively)

Blood loss will be measured in ml (cc).

次要结局

  • Amount of Perigraft Collection(up to 48 hours postoperative)
  • Hemostasis achievement(Baseline (Intraoperatively))
  • Drop in Hemoglobin(up to 48 hours postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Anil Kapoor

MD, FRCSC

St. Joseph's Healthcare Hamilton

研究点 (2)

Loading locations...

相似试验

Hemopatch Versus No Hemopatch (Renal Transplant) | 临床试验